PHCS News

Novo Nordisk Gift to Benefit Diabetes Programs, Outpatient Rehabilitation at UMCPP

Mar 20, 2013

Novo Nordisk Inc., a global pharmaceutical company with U.S. headquarters in Princeton, donated $550,000 to support diabetes programs at University Medical Center of Princeton at Plainsboro (UMCPP) and to help fund construction of a new Outpatient Rehabilitation center on the hospital campus.

Combined with prior gifts, Novo Nordisk has contributed more than $1 million to Design for Healing, the capital campaign for UMCPP.

To acknowledge the latest gift, the 2,500-square-foot Outpatient Rehabilitation facility—part of Princeton Fitness & Wellness Center at Plainsboro, which opens this month next door to UMCPP—will be named "Krogh Outpatient Rehabilitation" to honor Novo Nordisk's founders, Drs. August and Marie Krogh.

"As a world leader in diabetes care and an active member of this community, Novo Nordisk considers this gift an extension of our triple bottom line philosophy," said Jerzy Gruhn, President of Novo Nordisk Inc. and also a Trustee of Princeton HealthCare System, which includes UMCPP. "Supporting diabetes treatment and the construction of this comprehensive healthcare campus aligns with our belief that our neighbors and employees and should have access to high quality care close to home."

Staffed by a skilled team of licensed physical therapists, Krogh Outpatient Rehabilitation is the newest location of UMCPP's Outpatient Rehabilitation Network. The new site features an open physical therapy area, individual treatment rooms, and access to Princeton Fitness & Wellness Center's amenities, such as cardio equipment, strength-training machines and a therapy pool.

PHCS offers a continuum of rehabilitation services that includes the Outpatient Rehabilitation Network, an inpatient Acute Rehabilitation Unit at UMCPP and in-home rehabilitation provided through Princeton HomeCare.

Launched in 2008 and concluding at the end of this month, Design for Healing has raised more than $159 million, making it one of the most successful capital campaigns ever for a hospital of UMCPP's size. The original fundraising goal—$115 million—was eclipsed by early 2011. Funds raised through the capital campaign facilitated new clinical and operational efficiencies and enhanced Princeton HealthCare System's capabilities in cardiac care, emergency services, maternity and neonatal care, and surgical interventions.


About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com. For more information about our US activities, follow us on Twitter at @NovoNordiskUS.

About Princeton HealthCare System
Princeton HealthCare System is a comprehensive, integrated healthcare system that strives to anticipate and serve the lifelong needs of central New Jersey residents, including acute care hospital services through University Medical Center of Princeton at Plainsboro, behavioral healthcare through Princeton House Behavioral Health, rehabilitation, home care, hospice care, ambulatory surgery, a primary and specialty medical practice, and fitness and wellness services. For more information, visit www.princetonhcs.org.